What is the most likely cause and recommended evaluation for a patient with hemoglobin 9.7 g/dL, low red blood cell count, elevated mean corpuscular volume and mean corpuscular hemoglobin, and normal mean corpuscular hemoglobin concentration and red cell distribution width?

Macrocytic Anemia with Vitamin B12 or Folate Deficiency

The laboratory pattern of hemoglobin 9.7 g/dL, low RBC count, elevated MCV and MCH, with normal MCHC and RDW, most strongly indicates macrocytic anemia caused by vitamin B12 or folate deficiency.

Why This Pattern Points to Megaloblastic Anemia

• Low RDW (normal) together with elevated MCV indicates a uniform population of enlarged red cells, which is the hallmark of megaloblastic anemia and helps differentiate it from iron-deficiency anemia (which typically shows high RDW). 1

• A low or normal reticulocyte count in macrocytic anemia points to impaired erythropoiesis (vitamin B12/folate deficiency or bone-marrow failure), whereas an elevated reticulocyte count would suggest hemolysis or recent marrow regeneration. 2

• Megaloblastic anemia (vitamin B12 or folate deficiency) characteristically presents with macrocytosis and a low/normal reticulocyte count. 2

Immediate Diagnostic Workup

First-Line Laboratory Tests

• Measure serum vitamin B12 and folate levels immediately to confirm or exclude megaloblastic anemia. 2

• Obtain a peripheral blood smear to look for hypersegmented neutrophils (the earliest and most specific morphologic sign of megaloblastic anemia), oval macrocytes, or pancytopenic patterns. 2

• Order an absolute reticulocyte count to differentiate impaired erythropoiesis (low/normal count) from hemolysis or acute blood loss (elevated count). 2

Essential Iron Studies

• Check serum ferritin and transferrin saturation to rule out co-existing iron deficiency, which can mask macrocytosis and normalize the MCV. 2

• If iron studies reveal ferritin < 30 µg/L (or < 100 µg/L with inflammation), iron deficiency may be present and could be concealing a more severe macrocytic process. 1, 2

Critical Clinical History Elements

• Review medication exposure, focusing on thiopurines (azathioprine, 6-mercaptopurine), chemotherapy agents, anticonvulsants, and methotrexate, as these can induce macrocytosis. 2

• Assess gastrointestinal history including diarrhea, malabsorption, prior gastric surgery, or inflammatory bowel disease, which raise the risk of vitamin B12 deficiency. 2

• Thiopurine therapy (azathioprine, 6-mercaptopurine) frequently produces homogeneous macrocytosis, especially in patients with inflammatory bowel disease. 2

Diagnostic Algorithm

1. Obtain reticulocyte count immediately to direct subsequent testing. 2

2. If reticulocyte count is low/normal:

   • Measure vitamin B12 and folate levels
   • Perform thyroid-stimulating hormone and liver-function tests
   • Conduct thorough medication review for macrocytosis-inducing agents
   • Consider bone-marrow referral if pancytopenia is present 2

3. If reticulocyte count is elevated:

   • Evaluate for hemolysis with haptoglobin, LDH, indirect bilirubin, and peripheral smear 2

4. Order iron studies in all patients to exclude concurrent iron deficiency. 2

5. If initial investigations are nondiagnostic, refer to hematology for possible bone-marrow examination or hemoglobin electrophoresis. 2

Common Diagnostic Pitfalls

• Mixed micro- and macro-cytosis can neutralize the MCV, yielding a normal MCV but an elevated RDW; therefore, iron studies remain essential even when RDW is low. 2

• In elderly individuals or patients with inflammatory bowel disease, simultaneous iron and vitamin B12 deficiencies can neutralize the mean corpuscular volume, yielding a normal MCV but an elevated red-cell distribution width; this mixed-deficiency pattern mandates assessment of both iron and B12 status. 1

• Iron deficiency may coexist with vitamin B12 or folate deficiency; an elevated red-cell distribution width may signal combined deficiencies. 3

If Hemolysis Is Suspected

• In patients with an elevated absolute reticulocyte count suggestive of hemolysis, order a hemolysis panel that includes low haptoglobin, high lactate dehydrogenase, elevated indirect bilirubin, and a peripheral smear for schistocytes to confirm red-cell destruction. 1

• Perform a direct antiglobulin (Coombs) test to identify autoimmune hemolytic anemia when laboratory evidence points to hemolysis. 1